Prof Nigel Garrett appointed Leader of the CAPRISA eThekwini Research Site
Professor Nigel Garrett, Head of the CAPRISA HIV Pathogenesis and Vaccine Research Programme has been appointed Leader of the CAPRISA eThekwini Research Site (ECRS). Garrett brings a wealth of experience as a specialist physician in HIV and Sexual Health and has conducted more than 20 randomized clinical trials and large cohort studies related to HIV prevention and COVID-19 vaccines. He is the CAPRISA Lead to the HIV Vaccine Trials Network (HVTN). Professors Salim and Quarraisha Abdool Karim congratulated Garrett on his appointment and wished him ‘every success in this new role’.
Garrett is a Technical Expert Consultant of the South African National Strategic Plan (NSP) for HIV, TB and STIs 2023 – 2028 and provides input on objectives and interventions on reducing STIs, cervical cancer and hepatitis that draws on his extensive experience in evaluating point of care diagnostics and STI interventions.
Garrett says, he is looking forward to lead one of the flagship clinical research sites at CAPRISA and engage with all stakeholders to continue to strive for clinical excellence.